Protective Effects of Sodium-Glucose Transporter 2 Inhibitors on Atrial Fibrillation and Atrial Flutter: A Systematic Review and Meta- Analysis of Randomized Placebo-Controlled Trials.

Front Endocrinol (Lausanne) · 2021 · PMC8018283 · PMID 33815278

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

borderline significantP = 0.07so close (0.05 < p ≤ 0.1)

However, the risks of AF incidence between SGLT2i and placebo was borderline significant (0.73% vs. 0.90%; RR 0.83; 95% CI 0.67–1.01; P = 0.07).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.